Bandaríkin - enska - NLM (National Library of Medicine)

hahnemann laboratories, inc. - aluminum sulfate (unii: 34s289n54e) (aluminum sulfate anhydrous - unii:i7t908772f) -

Bandaríkin - enska - NLM (National Library of Medicine)

hahnemann laboratories, inc. - aluminum sulfate (unii: 34s289n54e) (aluminum sulfate anhydrous - unii:i7t908772f) -

Bandaríkin - enska - NLM (National Library of Medicine)

hahnemann laboratories, inc. - aluminum sulfate (unii: 34s289n54e) (aluminum sulfate anhydrous - unii:i7t908772f) -

Bandaríkin - enska - NLM (National Library of Medicine)

hahnemann laboratories, inc. - aluminum sulfate (unii: 34s289n54e) (aluminum sulfate anhydrous - unii:i7t908772f) -

Bandaríkin - enska - NLM (National Library of Medicine)

hahnemann laboratories, inc. - aluminum sulfate (unii: 34s289n54e) (aluminum sulfate anhydrous - unii:i7t908772f) -

Bandaríkin - enska - NLM (National Library of Medicine)

hahnemann laboratories, inc. - aluminum sulfate (unii: 34s289n54e) (aluminum sulfate anhydrous - unii:i7t908772f) -

Malta - enska - Medicines Authority

waymade bv herikerbergweg 88, 1101cm amsterdam , netherlands - dexamfetamine sulfate - tablet - dexamfetamine sulfate 5 mg - psychoanaleptics

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aspirin, quantity: 100 mg; clopidogrel hydrogen sulfate, quantity: 97.875 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: hyprolose; mannitol; carnauba wax; colloidal anhydrous silica; maize starch; microcrystalline cellulose; hydrogenated castor oil; stearic acid; macrogol 6000; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide red - apx-clopidogrel is a fixed-dose combination product intended as continuation of therapy in patients with acute coronary syndrome already initiated with separate clopidogrel and aspirin products: unstable angina or non-st-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). apx-clopidogrel is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or pci, with or without stent). st-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. in this population, apx-clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Malta - enska - Medicines Authority

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - aluminium hydroxide, magnesium hydroxide - oral suspension - aluminium hydroxide 460 mg magnesium hydroxide 400 mg - drugs for acid related disorders

Malta - enska - Medicines Authority

ipca produtos farmaceuticos unipessoal lda rua jose nogueira vaz no 8b 2625-099 povoa de santa iria , portugal - film-coated tablet - hydroxychloroquine sulfate 200 mg - antiprotozoals